216 results on '"Petrou, Panagiotis"'
Search Results
2. The economics of TAVI: A systematic review
3. Evaluating Greek pharmacists' attitudes and barriers regarding medicines adherence.
4. Methodological considerations in injury burden of disease studies across Europe: a systematic literature review
5. Correction to: A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
6. A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases
7. The efficiency of TAVI in intermediate and low-risk Japanese patients.
8. Economic Evaluation of Monoclonal Antibodies in Metastatic Colorectal Cancer: A Systematic Review
9. The 2019 introduction of the new National Healthcare System in Cyprus
10. The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots’ Health: The Memorandum Is Dead, Long Live the Memorandum
11. Does X(a) mark the spot? An indirect mixed treatment comparison of Xa inhibitors compared to warfarin for patients with atrial fibrillation
12. Cost-effectiveness of Left Atrial Appendage Closure with WATCHMAN device for non-valvular atrial fibrillation patients in Japan. Are the policy implications big in Japan?
13. Improving quality care for diabetes in the community : What do Cypriot patients want?
14. A quasi-experimental study for inappropriate laboratory utilization from a payer perspective in Cyprus
15. Healthcare reforms in Cyprus 2013–2017: Does the crisis mark the end of the healthcare sector as we know it?
16. Implementing a Managed Entry Agreement Framework in Cyprus
17. Battling Tuberculosis beyond antibiotics
18. Implementing shared-decision-making for diabetes care across country settings: What really matters to people?
19. Pharmaceutical price comparisons across the European Union and relative affordability in Cyprus
20. Global Budget for Cyprus’ National Health System: The Promised Land or a No Man’s Land?
21. Long-term effect of tendering on prices of branded pharmaceutical products
22. A mixed treatment comparison for short- and long-term outcomes of bare-metal and drug-eluting coronary stents
23. Budget impact analysis of daratumumab for light chain amyloidosis in Cyprus
24. Price Determinants of the Tendering Process for Pharmaceuticals in the Cyprus Market
25. Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment
26. Burden of disease attributable to risk factors in European countries: a scoping literature review
27. Comparison of validation protocols for blood pressure measuring devices in children and adolescents
28. Tendering for pharmaceuticals as a reimbursement tool in the Cyprus Public Health Sector
29. Seeking to introduce a pharmacoeconomics framework in Cyprus
30. Is it a chimera? A systematic review of the economic evaluations of CAR-T cell therapy - an update.
31. A Framework for Applying Health Technology Assessment in Cyprus: Thoughts, Success Stories, and Recommendations
32. Methodological considerations in injury burden of disease studies across Europe:a systematic literature review
33. Value-Based pricing and the end of pharmaceutical pricing as we know it? A case study on sorafenib and axitinib
34. An Interrupted Time-Series Analysis to Assess Impact of Introduction of Co-Payment on Emergency Room Visits in Cyprus
35. A systematic review and meta-analysis of vitamin D and calcium in preventing osteoporotic fractures
36. Burden of non-communicable disease studies in Europe: a systematic review of data sources and methodological choices
37. Additional file 1 of Methodological considerations in injury burden of disease studies across Europe: a systematic literature review
38. The notion of Surrogacy in Health Technology Assessment: an insight in the processes of Germany, UK and France
39. A Systematic Review of the Economic Evaluations of Belimumab in Systemic Lupus Erythematosus
40. Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective
41. The power of r – pharmaceutical sales decomposition in Cyprus public healthcare sector and determinants of drug expenditure evolution: any lessons learned?
42. Cost–effectiveness of sorafenib compared to best supportive care in second line renal cell cancer from a payer perspective in Cyprus
43. A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic
44. A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases.
45. Assessing the pricing and benefits of oncology products: an update
46. Budget impact analysis: can we afford the added value?
47. The tyranny of the SW quadrant
48. A systematic review of the economic evaluations of trastuzumab in metastatic breast cancer
49. Eliciting health state utilities in Japanese diabetic and obese patients through the time trade-off method. Does the conjecture fat and happy stand true?
50. Is it a Chimera? A systematic review of the economic evaluations of CAR-T cell therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.